Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Expert Review of Vaccines
|
June 29, 2021
The current and future role of nanovaccines in HIV-1 vaccine development
Christopher P Karch, Gary R Matyas
Vaccine
|
June 1, 2011
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A
Gary R Matyas, Carl R Alving
ACS Omega
|
May 6, 2024
A Reliable Quantification of Cholesterol and 25-Hydroxycholesterol in Liposomal Adjuvant Formulation by Liquid Chromatography High-Resolution Tandem Mass Spectrometry
Erwin G Abucayon, Scott Sweeney, Gary R Matyas
Biochimica Et Biophysica Acta
|
December 17, 2014
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate
Zoltan Beck, Gary R Matyas, Carl R Alving
Frontiers in Immunology
|
February 10, 2023
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
Carl R Alving, Mangala Rao, Gary R Matyas
Journal of Immunological Methods
|
August 8, 2002
Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies
Gary R Matyas, Mangala Rao, Carl R Alving
Biochemical and Biophysical Research Communications
|
July 25, 2020
Biophysical characterization of polydisperse liposomal adjuvant formulations
Pushpendra Singh, Gary R Matyas, Alexander Anderson, et al.
Methods in Enzymology
|
January 13, 2004
Oil-in-water liposomal emulsions for vaccine delivery
Gary R Matyas, Jean M Muderhwa, Carl R Alving
Methods in Molecular Biology (Clifton, N.J.)
|
April 15, 2016
Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities
Oscar B Torres, Carl R Alving, Gary R Matyas
Nanomedicine (London, England)
|
March 15, 2021
The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back
Christopher P Karch, Peter Burkhard, Gary R Matyas, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Expert Review of Vaccines
|
June 29, 2021
The current and future role of nanovaccines in HIV-1 vaccine development
Christopher P Karch, Gary R Matyas
Vaccine
|
June 1, 2011
Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A
Gary R Matyas, Carl R Alving
ACS Omega
|
May 6, 2024
A Reliable Quantification of Cholesterol and 25-Hydroxycholesterol in Liposomal Adjuvant Formulation by Liquid Chromatography High-Resolution Tandem Mass Spectrometry
Erwin G Abucayon, Scott Sweeney, Gary R Matyas
Biochimica Et Biophysica Acta
|
December 17, 2014
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysate
Zoltan Beck, Gary R Matyas, Carl R Alving
Frontiers in Immunology
|
February 10, 2023
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21
Carl R Alving, Mangala Rao, Gary R Matyas
Journal of Immunological Methods
|
August 8, 2002
Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies
Gary R Matyas, Mangala Rao, Carl R Alving
Biochemical and Biophysical Research Communications
|
July 25, 2020
Biophysical characterization of polydisperse liposomal adjuvant formulations
Pushpendra Singh, Gary R Matyas, Alexander Anderson, et al.
Methods in Enzymology
|
January 13, 2004
Oil-in-water liposomal emulsions for vaccine delivery
Gary R Matyas, Jean M Muderhwa, Carl R Alving
Methods in Molecular Biology (Clifton, N.J.)
|
April 15, 2016
Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities
Oscar B Torres, Carl R Alving, Gary R Matyas
Nanomedicine (London, England)
|
March 15, 2021
The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back
Christopher P Karch, Peter Burkhard, Gary R Matyas, et al.
Page
of 12